Eros Regulatory News (EROS)

Eros International Plc Announces Filing of F-1 Registration Statement

London, U.K. - March 30, 2012 - Eros International Plc (LSE AIM: EROS) (the "Company"), a leading global company in the Indian film entertainment industry, today announced that it has filed a registration statement on Form F-1 with the United States Securities and Exchange Commission relating to a proposed initial public offering of its A Ordinary Shares.

The number of shares to be offered and the price range for the offering have not yet been determined. Deutsche Bank Securities Inc., BofA Merrill Lynch, Citigroup and UBS Securities LLC are acting as joint-bookrunners for the offering.

When available, a copy of the preliminary prospectus may be obtained from Deutsche Bank Securities Inc., via email at prospectus.cpdg@db.com, or at Deutsche Bank Securities Inc., Attn: Prospectus Department, 100 Plaza One, Jersey City, NJ 07311, or via telephone: (800) 503-4611; BofA Merrill Lynch, via email at dg.prospectus_requests@baml.com, or at BofA Merrill Lynch, Attn: Prospectus Department, 4 World Financial Center, New York, NY 10080; Citigroup at Prospectus Delivery Department, Brooklyn Army Terminal, 140 58th Street, 8th Floor, Brooklyn, NY 11220, or via telephone: (800) 831-9146; or UBS Securities LLC at Prospectus Department, 299 Park Avenue, New York, NY 10171, or via telephone: (888) 827-7275.

A registration statement relating to the Company's A Ordinary Shares has been filed with the United States Securities and Exchange Commission, but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any offer or sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.

Some of the information presented in this press release and in related comments by the Company's management contains forward-looking statements.  In some cases, these forward-looking statements are identified by terms and phrases such as "aim," ''anticipate,'' ''believe,'' "feel," "contemplate," ''intend,'' ''estimate,'' ''expect,'' ''continue,'' ''should,'' ''could,'' ''may,'' ''plan,'' ''project,'' ''predict,'' ''will,'' "future," "goal," "objective," and similar expressions and include references to assumptions and relate to the Company's future prospects, developments and business strategies.  Similarly, statements that describe the Company's strategies, objectives, plans or goals and statements regarding the proposed offering and the anticipated costs of these transactions are forward-looking statements and are based on information available to the Company as of the date of this press release.  Forward-looking statements are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those contemplated by the relevant statement.  Such risks and uncertainties include a variety of factors, some of which are beyond the Company's control.  In particular, such risks and uncertainties include market conditions.  Information concerning these and other factors that could cause results to differ materially from those contained in the forward-looking statements is contained under the caption "Risk Factors" in the Company's Registration Statement on Form F-1 filed with the U.S. Securities and Exchange Commission.  The Company undertakes no obligation to revise the forward-looking statements included in herein to reflect any future events or circumstances, except as required by law. The Company's actual results, performance or achievements could differ materially from the results expressed in, or implied by, these forward-looking statements.

Contact:

Jeff Majtyka or Brad Edwards

Brainerd Communicators

+212-986-6667

Sean Hanafin

Chief Corporate & Strategy Officer

+44 (0)207 258 9909